The company has prepared practice marketing materials to support the campaign to educate pet owners on the signs of anxiety in cats and dogs, which are available from its Account Managers.
The campaign is being fronted by TV personality and radio presenter, Kate Lawler (pictured), who has taken on the role of official ambassador having experienced anxiety in her rescue Terrier cross, Shirley.
Ceva has partnered with Battersea Dogs and Cats Home for the campaign and will be making a donation of £1 for every Adaptil product sold during March.
http://www.petanxiety.co.uk
Prac-tic® – the spot-on flea and tick treatment from Novartis Animal Health has added a new claim to its licence.
It now states that adult fleas are killed before they lay eggs for a minimum of four weeks after treatment and, as the product completely eliminates egg production, it also breaks the flea life cycle.
Petplan has issued a last call for entries to the 2009 Petplan Veterinary Awards, and announced that comedian Jason Manford, best known as team captain on Channel 4's 8 out of 10 Cats, will be the compere.
The Veterinary Awards aim to honour the special stars within the veterinary profession and nominations remain open under four different categories:
Petplan says it has already received hundreds of nominations from clients and industry professionals alike. To make sure your colleagues are considered for the accolade log onto www.petplan.co.uk/vetawards to nominate. Entries must be in by 6th February 2009.
The Petplan Veterinary Awards are to be held on Thursday 2nd April on the first evening of BSAVA.
The RCVS has launched a new animated video to help promote Practice Standards Scheme (PSS) accredited practices to the public, and explain the benefits of the scheme.
Launched in 2005, almost 60% of practices are now part of the PSS, which requires them to submit to a rigorous inspection every four years and meet a stringent standards across a wide range of areas including cleanliness and hygiene, facilities and equipment, staff training and development and customer service. Practices may also be subject to spot-checks between inspections.
Jacqui Molyneux, who heads up the RCVS Practice Standards Group said: “Our new video is a light-hearted explanation of the Practice Standards Scheme, how it can help animal owners decide which practice to go to and reassure them about the standards they can expect to find at an RCVS-accredited practice.”
The College says a similar version of the video will soon be available for RCVS-accredited practices to show to their clients, either on their own websites and social media channels, or in the waiting room.
Jacqui said: “Not only do we want to spread the word about the benefits of the Practice Standards Scheme and suggest animal owners look for the RCVS-accredited practice logo, but we also want to give accredited practices an engaging way of telling their clients about their achievement.
“Gaining RCVS accreditation is not easy, so accredited practices deserve every opportunity to demonstrate to their clients their commitment to supporting high standards of veterinary care. This fun two-minute video should help them do just that.”
Animal owners can search for an RCVS-accredited practice in their area, or elsewhere in the UK, using Find A Vet – the College’s online search tool – at www.findavet.org.uk.
The British Veterinary Association has reacted to the Comprehensive Spending Review announced by the Government.
BVA President, Harvey Locke said: "Clearly this is a substantial hit on Defra's overall budget but there are some elements to welcome.
"We are pleased with the commitment to protecting the science base and Defra's clear focus on tackling TB and we await with interest future announcements on how the Government plans to introduce responsibility and cost sharing.
"However, the Government has put a lot of emphasis on securing flood defences within Defra's budget and we remain concerned that other crucial animal health and welfare issues could be further squeezed in this massively reduced budget.
"The BVA will continue to champion these health and welfare issues to ensure they remain a priority for the Department."
Langford Veterinary Services, a fully owned subsidiary of the University of Bristol, has announced the opening of a new standing equine magnetic resonance imaging (MRI) facility at the university's equine centre.
The equine MRI facility completes the diagnostic imaging facilities in the School, which include a 16-slice CT scanner for small animals and standing horses, digital radiography, high-resolution fluoroscopy, diagnostic ultrasound, echocardiography and scintigraphy with a high-resolution 1.5 tesla MRI scanner, available seven days a week.
Evita Busschers, Senior Teaching Fellow and orthopaedic surgeon in the equine centre, said: “We are very grateful to the Trustees of the Alborada Trust and the Langford Trust who have provided generous support for the MRI facility. The new imaging facility will enable us to provide an even better and more complete service for our equine patients and completes the diagnostic imaging facilities available at the centre.
“Equine MRI offers the ability to image soft tissue structures and identify soft tissue injuries that cannot be demonstrated with other diagnostic imaging modalities and therefore has major additional value in providing a diagnosis and prognosis in lameness evaluations.”
Miles Littlewort, a trustee from the Alborada Trust added: “Donating the money is the easy bit but ensuring that it has been used where it should be and that it has made the necessary difference is much more challenging. We are so pleased to have had the opportunity to support the Langford Trust and their work to improve animal health and welfare. We are delighted to have attended the opening, to meet the clinicians who will use the magnificent facility and to learn about the clinical research which gives all veterinary surgeons evidence-based information to enhance diagnosis and treatment for all patients.”
The day-long courses, each running from 9.30-5:00pm, will cover: basic mental health awareness; HR employment regulations and the legal position; the role of the line manager in supporting someone with poor mental health; making reasonable adjustments; planning 'return to work'; and designing and putting in place wellbeing action plans.
The courses will be run by Connecting with People, a social enterprise that develops and delivers high-quality training to employees with healthcare or safeguarding responsibilities.
Helen Sanderson, former VPMA President and representative on the Mind Matters Initiative Taskforce, said: "If you do one thing this year for your team I strongly recommend it be attending one of these courses. It provided me with invaluable information in recognising stress and depression in a team, as well as giving useful tools and tips on how to discuss and handle situations. I would encourage anyone to attend."
Lizzie Lockett, Director of Mind Matters, added: "It has been wonderful to see the response from the veterinary profession to our mental health awareness training sessions, but we know that managers can face particular challenges in supporting their team's mental health. Meanwhile, line managers play a key role in whether or not someone feels comfortable discussing a mental health issue, goes on to seek help, and, ultimately, returns to the workforce.
"We therefore designed these courses to provide very practical information for those in managerial positions, covering legal requirements as well as how to implement wellbeing strategies for colleagues."
The courses, which are subsidised by Mind Matters and the VPMA, cost £80 for VPMA members and £120 for non-members.
To book a place, visit the Mind Matters Eventbrite page: www.rcvsmindmatters.eventbrite.com
The Royal College is calling for views on the Day One Competences required of newly qualified veterinary surgeons, via an online survey.
The survey can be accessed from the RCVS website (www.rcvs.org.uk/consultations), and can be completed until 31 May.
The College says that the survey is the first step in a review of the Day One Competences, which define the level to be expected of new veterinary graduates when they first qualify. The competences set out in broad terms what is required of new graduates at the end of their veterinary degree, and provide the foundation for curriculum design and student assessment in UK veterinary courses.
RCVS Council member David Catlow, who chairs the Working Party undertaking the review, said: "The Day One Competences are deliberately general as they aim to convey the important principles that all students must master by the time they graduate, regardless of the precise curriculum they have followed, so they are safe to practise in a range of veterinary contexts from day one after they graduate.
"As it is over ten years since these competences were confirmed, we are reviewing them to ensure they remain valid, and to seek to ensure they reflect current and likely future expectations."
The Working Party will report to the Education Policy and Specialisation Committee (EPSC), and includes representatives from the veterinary schools and the British Veterinary Association (BVA), as well as a recent veterinary graduate.
Since being confirmed by the RCVS, the Day One Competences have also been adopted across Europe, through the European Association of Establishments for Veterinary Education (EAEVE), and in countries such as Australia.
The club is running a series of 5 sessions targeted at business owners.
Each session will comprise of a 20 minute intro, followed by 40 mins of discussion/Q&A/sharing of experiences around the chosen topic.
Session topics will include succession planning, life insurance and critical illness cover for you and your team.
How to conduct an effective PDR, boosting your revenue and profit share schemes are all in the pipeline.
SPVS says its Business Club is different to conventional CPD sessions, because it allows participants to share and discuss ideas, talk through problems and ask each other for advice.
The one-hour sessions will take place on Thursdays, starting at 7:30pm on 13th June, 18th July, 8th August, 19th September, 17th October
In the first, Pete Orpin, BVSc FRCVS from Anval Business Consultancy will present ‘How to nail succession planning’.
SPVS Members: FREE
Non-Members: £15 per session | £50 for bundle of 5
https://spvs.org.uk/spvs-business-club
The posters are designed to educate clients about what their pet should be drinking on a daily basis, according to their weight.
The company has also prepared a rehydration social media pack with content for practices to use on their social media feeds.
Posters can be requested and social media packs downloaded at: https://www.animalcare.co.uk/oralade-poster.
It will compare current prescription levels with two-year retrospective data to gain an understanding of prescribing behaviour.
It will also look at the proportion of prescriptions that are Highest Priority Critically Important Antimicrobials (HPCIAs).
Individual practice data will then be given to a dedicated AMS representative at each surgery who will be responsible for sharing it with their team - to gain an understanding of their prescribing for these conditions and to review actions which can be taken at practice level.
CPD on antimicrobial stewardship will be given to all practices to encourage responsible antimicrobial usage.
The research project will then capture ongoing data - from August 2024 until July 2025 - to show changes in antimicrobial prescribing.
The research is expected to provide an opportunity to build upon ongoing veterinary antimicrobial stewardship strategies.
This could include: using diagnostics to ensure accurate diagnoses and appropriate treatment plans, informing a change in prescribing behaviour, selecting antimicrobials responsibly, educating pet owners on antimicrobial resistance and using evidence-based guidance.
The clinical research project is being run by Kezia Wareham, Doctor of Philosophy student at Bristol Veterinary School (supervised by Dr Fernando Sanchez-Vizcaino, Dr Emi Barker, Dr Nicola Rooney and Dr Irene Bueno Padilla) and Deb Komianos, Regional Clinical Lead at CVS.
Deb said: “Antimicrobial resistance is one of the top ten global health threats and the figures projected by the WHO for attributable deaths are truly startling.
"To address the development of drug-resistant pathogens requires a One Health approach.
"It is not enough to pay lip service to AMS, we need to be leading the change."
Janssen Animal Health is advising vets to be on the look out for coccidiosis as the spring lambing season approaches: cases usually rise in March and peak in April and May.
According to the company, some reports also suggest that the incidence of coccidiosis in calves may apparently increase during the grazing months. However, vets are reporting that interpretation of laboratory tests used to confirm diagnosis, such as oocyst count, can be problematic due to the ubiquitous nature of the Eimeria parasite in the UK.
Young animals may be infected by oocysts shed by asymptomatic carriers or infected older cohort animals. Low levels of challenge can help young animals develop immunity but exposure to high oocyst numbers, particularly in combination with stress can lead to clinical and subclinical forms of the disease. Diagnosis can be problematic, particularly in subclinical cases of disease where failure to gain weight is the main presenting sign and in clinical cases the differential diagnoses include all causes of scour in young animals.
Janssen Animal Health has suggested a few indicators that may be useful in identifying cases of coccidiosis. The Vecoxan Coccidiosis Survey in 2008 and 2009 asked farmers about their experiences of coccidiosis and identified that bad weather was a major trigger particularly in lambs; while castration and weaning were also factors in calves. As the parasite life cycle is 21 days, vets should be alert to disease 2-3 weeks after a stressor event.
The company has also suggested a few guidelines to aid interpretation of laboratory results:
Janssen says Vecoxan (diclazuril) does not interfere with the development of immunity and kills all stages of the parasite in the host.
Purina has launched a range of services and support materials to help veterinary professionals approach the subject of nutrition with owners.
The Gastrointestinal Support Pack includes a GI handbook, "lunch and learn" educational sessions, a diagnostic support tool (available at www.purinavets.eu/giapplication) and a toolkit containing information sheets and diagnostic advice.
The company has also announced the result of some consumer research it conducted through One Poll in 2013, which revealed that 77% of dogs have experienced some form of digestive health issue, but only 20% of owners had visited their vet to discuss it. The research also found that 80% of owners would be willing to change their pet's diet if it would improve their digestion.
Esther Rawlinson, Purina UK Veterinary Affairs Manager said: "GI upsets and associated 'accidents' can be really distressing for both owner and pet but are seemingly suffered as 'just one of those things' by many. This needn't be the case though, as a lot of GI-related conditions could be prevented or at least managed by the correct nutritional advice and a specially formulated veterinary diet. By addressing nutrition at every consultation, vets can better identify those patients who suffer regular GI disturbance but whose owners do not feel it worthy of mentioning when in the clinic. The survey results show that there is a huge opportunity for vets to improve the health of many more of their clients' dogs and this is why Purina has introduced a range of GI services and support materials. We aim to help vets to include a nutritional assessment in all of their consultations."
For more information call PURINA PetCare Team on 0800 212 161.
Boehringer Ingelheim has launched Care and Connect a free online PPID aftercare service for horse owners, designed to help veterinary practices monitor their PPID case load and streamline the case management process.
The new service is part of Boehringer's 'Talk About Laminitis (TAL)' Awareness campaign.
The company says that PPID is the sixth most frequently encountered disease syndrome affecting equids in the UK1, and the new service should help engage owners and vets post diagnosis, thereby maximising treatment success.
Liz Barrett, equine business manager at Boehringer, said: “PPID is a progressive disease, so it is vital that veterinary surgeons remain at the centre of care, and that horses are monitored carefully following their initial diagnosis. However we recognise the high administrative demand associated with this, and TAL Care and Connect has been designed to reduce this as much as possible.”
TAL Care and Connect will be offered automatically to horse owners who take advantage of this year’s free* ACTH testing scheme, which will be available from July to November. Equine practices can also offer this aftercare service to all owners of previously diagnosed PPID cases.
Owners who join TAL Care and Connect will be able to set up a profile for their horse which allows all their ACTH results to be stored in one place. They will then receive the relevant reminders for follow-up ACTH testing which will make it easier for vets to monitor their patient’s progress over time.
In addition, owners can download an independently-written PPID information pack. Edited by Prof. Catherine McGowan with contributions from Dr Jo Ireland, Prof. Andy Durham, David Rendle and Dr Teresa Hollands, the pack includes advice on monitoring and follow-up ACTH tests, feeding, general care of the PPID patient and the link between laminitis and PPID.
Talk About Laminitis is supported by Redwings, The British Horse Society and World Horse Welfare, and will run from July until the end of October 2015. Horse owners can find out more and obtain their free ACTH voucher code at www.talkaboutlaminitis.co.uk.
For further information contact your local Boehringer territory manager or visit www.talkaboutlaminitis.co.uk.
*Cost of laboratory test
References
Each event is designed to help attendees with:
Each attendee will be given a complimentary annual Veterinary Osteoarthritis Alliance (VOA) membership.
Kai Crawshaw, Animalcare Brand Manager said: "We had excellent feedback from our first workshops, so we’re pleased to be able to reach veterinary practices in more locations around the UK.
"We also have plans to run more across the rest of the year.
"We hope that these events will lead to veterinary staff becoming more confident in dealing with OA in dogs and helping owners understand the options open to them."
All events start at 7:30pm (arrival from 7pm) and will finish approximately at 9:30pm.
Hot food and drinks will be provided.
https://www.animalcare.co.uk/oa-workshops
Here’s a gadget I’d love to get my hands on: the Zoombak advanced GPS pet locator, launched in the UK today.
The locator attaches to any dog collar, or indeed your car, husband, wife or teenager, and allows you to get a real time fix of their location by telephone, or on your computer. It costs £99.99 from pet retailers, with an additional £9.99 per month service subscription (£99.99 if paid annually upfront), which allows for an unlimited number of ‘locates’. Hot on its heels comes the Pawtrack, which will also cost £99.99 with a similar monthly subscription which allows for 1200 locates per month.
Pawtrack is being aimed at both cats and dogs, and whilst it is marginally smaller and lighter than the Zoombak, there isn’t a lot in it. Both are still probably too cumbersome for a cat, which is why Zoombak more pragmatically recommends its product for dogs over 7 kg.
Doubtless it won’t be long before they miniaturise the technology so that it’ll be the width of a nostril hair, thereby solving the problem of pet theft and loss completely. Meantime, these look like a practical and fun gadget for the owners of larger breeds that regularly go AWOL.
For more information on stocking Zoombak please contact Zoombak on 08708 033095.
Hot on the heels of the new license claim for Prac-tic comes the news that Novartis has launched new tasty Milbemax for cats.
The new tablet is the same small size as the original, but is beef-flavoured to ensure high palatability. According to Novartis, trials show that 100 per cent of cats accept the treatment with wet food and 83 per cent with dry food.
To help promote worming the palatable way, Novartis is offering practices some tasty marketing tools to use including posters, client leaflets, worming reminder pads and even a sturdy cut-out cat for reception.
Novartis will also be running a ‘Name Our Cat’ competition with the chance to win an iPod touch complete with an educational podcast; there are five to be won. Entry details can be obtained from Novartis Territory Managers.
For more information about new tasty Milbemax, please contact your Novartis Animal Health Territory Manager or call the Practice Support Line on 0800 854100.
A research project funded by The Horse Trust has found that various types of ocular tumours can be successfully treated with mitomycin C, a cytotoxic antibiotic isolated from a bacterium.
The research concludes that mitomycin C offers a safe and cost effective alternative to current treatment options such as surgery and radiation.
The research project was led by Fernando Malalana, while working as The Horse Trust's Clinical Scholar in Equine Internal Medicine at University of Liverpool. Fernando is now working as a Clinician Teacher in Equine Internal Medicine at the university.
Ocular tumours are more difficult to treat than tumours in other parts of the horse's body due to the risk of damaging the eye. In the study, Malalana investigated the use of mitomycin C in treating ocular squamous cell carcinoma, the most common ocular tumour in horses, and occular sarcoids, skin tumors that frequently affect the eyelids .
Mitomycin C is an antibiotic isolated from a bacterium, Streptomyces caespitosus. It is known to have cytotoxic effects and has been used to treat tumours in horses before, but only in combination with surgery.
Currently, the main method of treating ocular squamous cell carcinoma is by removing the tumour surgically or with radiation. Both treatments are costly and have a number of associated risks. There is also the risk of damage or scarring to the eye.
Fourteen horses with ocular squamous cell carcinoma, three of which were affected bilaterally, were included in the study. Mitomycin C was applied to the conjunctival sac of the affected eye; in some of the cases the treatment was combined with surgery. Malalana found that of the 8 eyes treated with mitomycin C alone, clinical resolution occurred in 6 cases. Of the 9 eyes treated with both surgery and mitomycin C, clinical resolution occurred in 7 cases.
Mitomycin C was also used to treat various types of sarcoids found in the eye. Currently, the most effective treatment for occular sarcoids is radioactive wire. However, radioactive wire treatment is not ideal as it is expensive, only offered in two locations in the UK, and has potential health risks to the vet applying the wire due to exposure to radioactivity.
Six horses and two donkeys with occular sarcoids, including one horse that was affected bilaterally, were treated with mitomycin C, which was injected directly into the tumour. Malalana found that of the nine nodular and fibroplastic occular sarcoids treated with the antibiotic, all were completely cleared. However, the vets did not have good results with verrucous sarcoids.
Malalana said: "The results of this research should offer hope to the owners of horses that have eye tumours. We have already been contacted by vets from across Europe to find out more information about this treatment and hope that it will be offered to more horses with occular tumours in the future".
Vets at the University of Liverpool are now testing the use of mitomycin C on other tumours that are difficult to treat surgically, including melanomas near the horse's anus. So far, two cases have been treated, but it is too early to tell whether treatment has been successful.
Malalana's research has been submitted to Veterinary Ophthalmology journal.
Woodley Equipment Co Ltd has announced the launch of the new, improved i-STAT® 1 Portable Critical Care Analyser. According to the company, the new i-STAT 1 analyser offers the same extensive test menu as the original analyser, plus the new CHEM8+ cartridge. The CHEM8+ panel provides many of the tests typically needed for quick general or emergency assessment, with just one cartridge. The i-STAT 1 analyser also provides new testing platforms, such as immunodiagnostic capability that will allow additional tests to be released in the future. Other improvements include the Cardiac Troponin test and Glucose strip reader, as well as infrared printer connectivity, upgraded storage capacity and ergonomic improvements. The i-STAT handheld analysers are the only handheld analysers available for veterinary medicine that provide vets with critical care electrolyte, blood gas, chemistry and basic hematology results in two minutes, from three drops of blood. Mike Wickham, Managing Director of Woodley Equipment said, “The new i-STAT 1 Handheld Clinical Analyser and original i-STAT analysers enable vets to make critical care decisions for their patients, whether in-practice or in the field.”
Defra has published an epidemiology report into the Avian Influenza outbreak confirmed in Oxfordshire on 4 June. The report concludes that, at as of 11th June, the outbreak was confined to a single premises, and there is no evidence of infection in the Protection Zone or of spread to any other premises. However, investigations continue. The report suggests that it is possible that the Highly Pathogenic H7N7 Avian influenza derived from a Low Pathogenic strain already present on the farm. Analysis and investigations are ongoing, and a number of source hypotheses are being considered. Chief Veterinary Officer, Nigel Gibbens, said: "The UK is at a constant but low level of risk of the introduction of Avian Influenza, and the report highlights the need for flock owners and poultry vets to remain vigilant for signs of disease, including the possibility of low pathogenic Avian Influenza. I would encourage all keepers to maintain good quality records and practise high standards of biosecurity." The Protection and Surveillance Zones remain in place. Further surveillance, testing and epidemiological work on this outbreak are ongoing.
The report can be viewed here:
http://www.defra.gov.uk/animalh/diseases/notifiable/disease/ai/latest-situation/index.htm
Would-be candidates in the Royal College of Veterinary Surgeon Council and Veterinary Nurse Council elections are reminded that the nominations deadline is 5pm on 31 January 2013.
Veterinary surgeons need two nominations from veterinary surgeons, and veterinary nurses two nominations from veterinary nurses, to stand in the respective elections.
Veterinary surgeons and veterinary nurses not presently on either Council can nominate one candidate each.
Nomination forms, full instructions and guidance notes are available from www.rcvs.org.uk/rcvscouncil13 and www.rcvs.org.uk/vncouncil13.
Six seats are due to be filled on RCVS Council, and two on VN Council. Those elected will take their seats on RCVS Day next July, to serve four-year terms. Council members will be expected to spend at least six to eight days a year attending Council and Committee meetings, working parties and subcommittees (for which a loss-of-earnings allowance is available).
Boehringer Ingelheim has announced the results of an independent three-year study which demonstrates that dogs suffering from the most common type of heart failure lived longer (average time in the study of 267 days vs. 140 days) when treated with the product Vetmedin (pimobendan) compared with the ACE inhibitor benazepril hydrochloride.
According to Boehringer, results from the QUEST (Quality of Life and Extension of Survival Time) study, published in the September/October 2008 issue of the Journal of Veterinary Internal Medicine, mark a significant milestone in canine cardiac health.
25% of all small to medium-sized dogs over the age of seven are likely to suffer from heart disease at some point in their life, and 75% of those cases are caused by myxomatous mitral valve disease (MMVD), sometimes known as "valvular insufficiency" or "endocardiosis".
Adrian Boswood from the Royal Veterinary College, London, a Veterinary Cardiology Specialist and a lead-investigator on the study, said: "With QUEST demonstrating that dogs treated with Vetmedin live on average nearly twice as long as those on benazepril, it is now time for us as veterinary cardiologists and practising veterinarians to look again at how we are treating our patients suffering from this serious condition."
Dr. Michael O'Grady from the Ontario Veterinary College, University of Guelph, a fellow lead-investigator added, "The QUEST study provides compelling evidence that dogs with the most common form of heart failure should be receiving Vetmedin® as an essential part of their treatment regimen."
QUEST is the largest international study ever conducted looking at treatment for congestive heart failure (CHF) caused by MMVD, with 260 dogs studied in 11 countries, across three continents, over a period of three years.
The study was conducted by a team of 32 independent veterinary cardiologists from Australia, Canada, France, Germany and the United Kingdom among other countries.
For more information on the QUEST study and on CHF caused by MMVD, see http://www.questtrial.com/
Plans for the introduction of a disciplinary mechanism for Registered Veterinary Nurses (RVNs) have been agreed by the RCVS Veterinary Nurses Council.
RVNs agree to account for their professional conduct and keep their skills and knowledge up to date: over 70% of eligible veterinary nurses have now joined the non-statutory Register.
The Veterinary Nurses Council agreed to a period of nearly three years between the opening of the Register and the College putting in place a disciplinary mechanism. This was to give RVNs time to get used to their new rights and responsibilities. Plans are now in place to introduce a disciplinary system from September 2010.
Charges could be brought against a veterinary nurse if found guilty of fraudulent registration, criminal convictions which render him or her unfit to practise as a veterinary nurse, or allegations of disgraceful professional conduct.
The sanctions would be the same as for veterinary surgeons, ie to remove a nurse's name from the Register (with the nurse eligible to apply for restoration after 10 months), or to suspend the nurse, with his or her name returning to the Register immediately after the period of suspension. A veterinary nurse would not be able to carry out Schedule 3 tasks while removed from the Register.
Complaints would initially be dealt with by the Veterinary Nurses Preliminary Investigation Committee (VN PIC), which will assess whether the complaints should be taken to the hearing stage. Three RVNs will sit on this committee. They will be joined by three members of the veterinary PIC, including either the RCVS President, or one of the Vice-Presidents, and one Lay Observer.
Meanwhile three RVNs will join existing members of the RCVS Disciplinary Committee (DC) to form a VN DC, to adjudicate on charges against a veterinary nurse. These individuals will not currently sit on VN Council. If the case were against a VN, the sitting panel would include at least one veterinary nurse, one veterinary surgeon and a lay person acting as chairman. A legal assessor would also sit with the Committee to offer advice.
If a case were to concern both a veterinary surgeon and a veterinary nurse, the preliminary investigation would be carried out in tandem but with separate disciplinary hearings.
Applications are invited for RVNs to sit on the new VN Preliminary Investigation or Disciplinary Committees. Anyone who would like further information should contact Lesley Evans, Manager, Executive Office (l.evans@rcvs.org.uk or 020 7222 2001) by 31 May 2009.
The Diabetic Clinical Score is a quick, standardised scoring system to record the clinical signs of diabetes in a patient, which was designed by Royal Veterinary College Internal Medicine Specialist Stijn Niessen
The scoring system has been turned into a pet diabetes app which allows clients to record and monitor the impact of treatment.
CVS' aim is to use the recently validated tool in over 80% of patient cases to improve the treatment and control of diabetes whilst supporting the practice team to develop their skills in managing the condition.
Participating practices will use the DCS, alongside blood glucose measurements, to diagnose and monitor patients.
Veterinary nurses will refer animals coming in for six-monthly Healthy Pet Club check-ups to a vet for a possible diabetes diagnosis, whilst vets diagnosing diabetes will introduce owners and patients to the DCS to record a diabetes log, to help manage the condition.
To upskill and develop colleagues in the use of the DCS, dedicated vet and nurse training sessions have been held by the clinical leadership team, including a kick-off ‘diabetes day’ which focussed on current thinking and introduced the DCS tool.
CVS teams have also grouped together to agree a coordinated approach to managing pets with diabetes in their practice.
Supporting diabetes resources have also been drafted for practices, including new clinical guidelines, supporting paperwork and CPD.
Lara Wilson, Regional Clinical Lead at CVS said: “Diabetes is notoriously difficult to diagnose and different vets can use different approaches to managing cases.
“The Diabetic Clinical Score will help the whole team around the patient – the owner, vet and veterinary nurse – to effectively and cohesively manage their care.
It will implement joined-up thinking and help to put a standardised disease management framework in place.
“It will be fantastic to see the benefits that the Diabetic Clinical Score will bring to our patients and practices.
"I am certain that this will help contribute towards them providing some of the best diabetes clinical diagnosis and care in our profession.”